Zolpidem Tartrate Tablet, Extended Release
Product Images NDC 71335-1180

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zolpidem Tartrate (NDC 71335-1180). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

B0207b5f 53fa 4b2c 8608 4095874aff98 01

Chemical structure of zolpidem tartrate, showing the molecular arrangement of the zolpidem component and the tartaric acid moiety.*

FDA Label Image

B0207b5f 53fa 4b2c 8608 4095874aff98 02

A line graph comparing plasma concentrations of zolpidem over time for 12.5 mg extended-release tablets versus 10 mg immediate-release tablets. The x-axis shows time in hours (0 to 8), and the y-axis shows zolpidem plasma concentrations in ng/mL (0 to 120). The graph illustrates different release profiles for the two formulations.*

FDA Label Image

Label Image (Lbl713351180)

The label for Zolpidem ER 12.5 mg extended-release tablets shows they are packaged by Bryant Ranch Prepack in Burbank, CA. It references comparison to Ambien CR 12.5 mg by Lupin Limited. The label includes warnings such as 'May Cause Drowsiness' and instructions to keep out of children's reach. It advises storage at 20°-25°C (68°-77°F). The quantity is 30 tablets with NDC 71335-1180-1.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.